Expert: FDA Improvement in Predictability, Review Requests Is Behind Approval Spike

A A
The FDA is realizing industry’s need for predictability and reasonable data requests during the review process, leading to the uptick in drug approvals seen so far this year, an expert says.

To View This Article:

Login

Subscribe To Drug Industry Daily